Browse Category

Earnings Reports News 31 January 2026 - 1 February 2026

Microchip (MCHP) stock slides into the weekend — here’s what traders watch before earnings

Microchip (MCHP) stock slides into the weekend — here’s what traders watch before earnings

Microchip Technology shares fell 4.33% to $75.92 Friday, with trading volume spiking to about 12 million shares. The drop followed a recent 52-week high and mirrored a 3.9% decline in the Philadelphia Semiconductor Index. Investors await Microchip’s earnings report on Feb. 5. Broader markets retreated amid renewed Fed and inflation concerns.
Arm stock slips after Friday chip selloff; CEO share-sale notice puts earnings in focus

Arm stock slips after Friday chip selloff; CEO share-sale notice puts earnings in focus

Arm’s U.S.-listed ADRs fell 2.8% to $105.36 at Friday’s close amid a broad chip stock selloff. CEO Rene Haas filed to sell 6,152 shares valued at about $654,000. The drop comes ahead of Arm’s fiscal third-quarter results due Feb. 4. Investors cited uncertainty over monetary policy after Donald Trump named Kevin Warsh as his pick for Federal Reserve chair.
Advanced Micro Devices stock slips on MI450 delay chatter — what investors watch before earnings

Advanced Micro Devices stock slips on MI450 delay chatter — what investors watch before earnings

AMD shares fell 6.13% to $236.73 Friday after SemiAnalysis warned of possible MI450 AI chip delays, though Wells Fargo’s Aaron Rakers disputed the claim and kept a $345 price target. The Nasdaq Composite dropped 0.94% as investors reacted to Kevin Warsh’s nomination for Fed chair. AMD reports earnings Feb. 3, with options pricing signaling an 8.9% implied move for Feb. 6 expiries.
Verizon stock jumps nearly 12% after earnings pop and buyback plan — what to know before Monday

Verizon stock jumps nearly 12% after earnings pop and buyback plan — what to know before Monday

Verizon shares jumped 11.8% to $44.52 Friday after strong Q4 subscriber growth and a $25 billion buyback announcement. The company added 616,000 postpaid phone subscribers and reported adjusted earnings of $1.09 per share on $36.4 billion revenue. Verizon raised its quarterly dividend and plans at least $3 billion in share repurchases for 2026. Markets reopen Monday with focus on whether the rally continues.
Amgen stock heads into earnings week after ending Kyowa Kirin eczema pact

Amgen stock heads into earnings week after ending Kyowa Kirin eczema pact

Amgen shares fell 0.3% to $341.88 Friday after disclosing plans to end its 2021 partnership with Kyowa Kirin, which will regain global rights to the eczema drug rocatinlimab. Amgen will report fourth-quarter and full-year earnings after markets close Feb. 3, with investors focused on pipeline priorities following the Kyowa Kirin exit.
Mitsubishi UFJ stock ends higher in Tokyo; India Shriram tie-up back in focus before earnings

Mitsubishi UFJ stock ends higher in Tokyo; India Shriram tie-up back in focus before earnings

Mitsubishi UFJ Financial Group shares rose 1.0% to 2,804.5 yen in Tokyo on Friday after a senior executive said Japanese automakers are considering partnerships tied to MUFG’s planned 20% stake in India’s Shriram Finance. Investors are awaiting MUFG’s third-quarter earnings on Feb. 4 for updates on overseas expansion and profit margins.
Linde stock price heads into earnings week: what to watch for LIN shares when markets reopen

Linde stock price heads into earnings week: what to watch for LIN shares when markets reopen

Linde plc stock closed at $456.97 Friday, up 0.43%. CEO Sanjiv Lamba will become chairman Jan. 31 as Stephen F. Angel retires from the board. The company will report fourth-quarter results Feb. 5 before the U.S. market opens. Wall Street fell Friday after President Trump nominated Kevin Warsh to lead the Fed and December PPI rose 0.5%, above forecasts.
PepsiCo stock price jumps as traders crowd into “defensive” names before earnings week

PepsiCo stock price jumps as traders crowd into “defensive” names before earnings week

PepsiCo shares rose 3.3% to $153.63 Friday, defying a broader market decline as trading volume spiked to 12.6 million shares. Coca-Cola and Mondelez also gained. Investors shifted to defensive stocks ahead of PepsiCo’s quarterly results, due Tuesday. The company is expected to update its 2026 forecast and cash return plans.
Novo Nordisk Class B stock price: Wegovy pill scripts hit 26,000 as earnings week approaches

Novo Nordisk Class B stock price: Wegovy pill scripts hit 26,000 as earnings week approaches

Novo Nordisk Class B shares closed down 0.23% at 369.55 Danish kroner Friday, capping a 7.9% slide over five sessions. U.S. prescriptions for oral Wegovy reached 26,109 in the week ending Jan. 23, after 3,071 in the first four days post-launch. The company faces rising competition in China and awaits EU approval for its MASH drug. Quarterly results and 2026 outlook are due Feb. 4.
Merck stock jumps to $110 as MRK heads into a big earnings week

Merck stock jumps to $110 as MRK heads into a big earnings week

Merck shares rose 1.8% to $110.27 Friday, outperforming a falling S&P 500 and closing about 2% below their 52-week high. Trading volume topped 19 million shares, well above rivals. Investors await Merck’s Feb. 3 earnings call and new inflation data that could affect rate expectations. Markets reacted to President Trump’s Fed pick and mixed inflation signals.
Philip Morris stock price rises into weekend as PM investors brace for Feb. 6 earnings webcast

Philip Morris stock price rises into weekend as PM investors brace for Feb. 6 earnings webcast

Philip Morris International shares closed Friday up 0.87% at $179.44, trading between $175.14 and $180.09 on volume of 8.24 million. The company will report fourth-quarter and full-year earnings on Feb. 6, the same day as the U.S. jobs report and a wave of major corporate results. The S&P 500 fell 0.4% Friday after Donald Trump named Kevin Warsh as his pick for Federal Reserve chair.
1 26 27 28 29 30 202

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Go toTop